These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17597821)

  • 1. Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria.
    Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
    J Invest Dermatol; 2007 Dec; 127(12):2790-4. PubMed ID: 17597821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exonic deletions as a cause of erythropoietic protoporphyria.
    Wood LH; Whatley SD; McKenna K; Badminton MN
    Ann Clin Biochem; 2006 May; 43(Pt 3):229-32. PubMed ID: 16704762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
    Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
    Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.
    Long ZB; Wang YW; Yang C; Liu G; Du YL; Nie GJ; Chang YZ; Han B
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):813-820. PubMed ID: 27704751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inheritance in erythropoietic protoporphyria].
    Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
    Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.
    Aurizi C; Schneider-Yin X; Sorge F; Macrì A; Minder EI; Biolcati G
    Mol Genet Metab; 2007 Apr; 90(4):402-7. PubMed ID: 17196862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
    Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.
    Parera VE; Koole RH; Minderman G; Edixhoven A; Rossetti MV; Batlle A; de Rooij FW
    Mol Med; 2009; 15(11-12):425-31. PubMed ID: 19693296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of erythropoietic protoporphyria in South Africa.
    Parker M; Corrigall AV; Hift RJ; Meissner PN
    Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
    Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
    Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
    Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
    Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
    Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
    Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular genetics of erythropoietic protoporphyria.
    Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.
    Holme SA; Whatley SD; Roberts AG; Anstey AV; Elder GH; Ead RD; Stewart MF; Farr PM; Lewis HM; Davies N; White MI; Ackroyd RS; Badminton MN
    J Invest Dermatol; 2009 Mar; 129(3):599-605. PubMed ID: 18787536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
    Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
    Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
    Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
    Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.